SCHEMBL7985535

SCHEMBL7985535

O=c1[nH]c(-c2ccccc2O)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.58
ALDH1A1 P00352 4/20 0.58
HPGD P15428 3/20 0.55
KMT2A Q03164 1/20 0.54
KDM4E B2RXH2 2/20 0.48
GUSB P08236 1/20 0.48
PDE5A O76074 4/20 0.46
CNOT7 Q9UIV1 2/20 0.46
PARN O95453 1/20 0.46
PNP P00491 2/20 0.43
GAA P10253 1/20 0.42
BRD4 O60885 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974850 0.87 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1HPGDKMT2AKDM4E
SCHEMBL7974644 0.86 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2AKDM4E
SCHEMBL7975265 0.84 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7988556 0.84 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1HPGDKMT2AGUSB
SCHEMBL7984948 0.83 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2AGUSB
SCHEMBL7975119 0.83 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2AGUSB
SCHEMBL7988785 0.83 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7985543 0.81 CNOT7 (0.54) SMN1; SMN2ALDH1A1HPGDKMT2AKDM4E
SCHEMBL7985798 0.81 GUSB (0.53) SMN1; SMN2ALDH1A1HPGDKMT2AKDM4E
SCHEMBL7985332 0.81 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed